glucose, (beta-d)-isomer has been researched along with Dermatoses in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (57.14) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (35.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schopf, RE | 1 |
Issekutz, AC; Movat, HZ; Movat, KW | 2 |
Ostgaard, G; Reed, RK | 1 |
Rhodes, EL; Rosling, AE; Watson, B; Williams, B | 1 |
Easmon, CS; Glynn, AA | 1 |
Hellewell, PG; Williams, TJ; Yarwood, H | 1 |
Basford, RE; Kaplan, SS; Kuhns, DB; Wechsler, HL; Zdziarski, UE | 1 |
Maegawa, H; Nakamura, I; Tabuchi, H; Tobe, K; Uno, S | 1 |
Fukuzawa, K; Haruna, M; Hayakawa, T; Hayase, T; Ito, Y; Kobuchi, S; Nakayama, H; Sakaeda, T; Sugano, A; Takahata, N; Takaoka, Y; Tohkin, M; Yoshioka, R | 1 |
Horwitz, S; Rendon, M | 1 |
Boo, SJ; Cha, JW; Cho, SJ; Hyun, CL; Hyun, JW; Kim, KC; Na, SY; Piao, MJ; Yao, CW; Zheng, J | 1 |
Baldisserotto, A; Beghelli, E; Copetti, S; Dal Toso, R; Malisardi, G; Manfredini, S; Scalambra, E; Vertuani, S | 1 |
1 review(s) available for glucose, (beta-d)-isomer and Dermatoses
Article | Year |
---|---|
Topical treatment of hyperpigmentation disorders.
Topics: Administration, Topical; Adrenal Cortex Hormones; Arbutin; Chromones; Drug Combinations; Free Radical Scavengers; Glucosides; Humans; Hydroquinones; Hyperpigmentation; Keratolytic Agents; Monophenol Monooxygenase; Niacinamide; Phytotherapy; Plant Preparations; Randomized Controlled Trials as Topic; Receptor, PAR-2; Retinoids; Skin Diseases; Skin Lightening Preparations; Skin Pigmentation | 2012 |
13 other study(ies) available for glucose, (beta-d)-isomer and Dermatoses
Article | Year |
---|---|
Crystal-phagocyte interaction in calcinosis interstitialis.
Topics: Adolescent; Calcinosis; Crystallization; Female; Granulocytes; Humans; Hydroxyapatites; Monocytes; Oxygen Consumption; Phagocytosis; Skin Diseases; Uric Acid; Zymosan | 1984 |
Enhanced vascular permeability and haemorrhage-inducing activity of zymosan-activated plasma.
Topics: Animals; Capillary Permeability; Complement C3; Hemorrhage; Leukocyte Count; Neutrophils; Rabbits; Skin; Skin Diseases; Time Factors; Zymosan | 1980 |
Enhanced vascular permeability and haemorrhage-inducing activity of rabbit C5ades arg: probable role of polymorphonuclear leucocyte lysosomes.
Topics: Animals; Capillary Permeability; Complement C5; Hemorrhage; Leukocyte Count; Lysosomes; Microscopy, Electron; Neutrophils; Rabbits; Skin; Skin Diseases; Zymosan | 1980 |
Increased negatively of interstitial fluid pressure in rat skin contributes to the edema formation induced by Zymosan.
Topics: Animals; Edema; Extracellular Space; Extravasation of Diagnostic and Therapeutic Materials; Female; Pressure; Rats; Rats, Wistar; Serum Albumin; Skin Diseases; Zymosan | 1993 |
Neutrophil function in some skin diseases using zymosan as a stimulus in the nitro-blue tetrazolium test.
Topics: Endotoxins; Escherichia coli; Humans; Neutrophils; Nitroblue Tetrazolium; Skin Diseases; Zymosan | 1978 |
Comparison of subcutaneous and intraperitoneal staphylococcal infections in normal and complement-deficient mice.
Topics: Animals; Antigens, Bacterial; Complement C3; Complement C5; Complement System Proteins; Injections, Intraperitoneal; Injections, Subcutaneous; Mice; Necrosis; Skin Diseases; Snake Venoms; Staphylococcal Infections; Staphylococcus aureus; Zymosan | 1976 |
Characteristics of oedema formation induced by N-formyl-methionyl-leucyl-phenylalanine in rabbit skin.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Bradykinin; Colchicine; Dinoprostone; Edema; Endotoxins; Histamine; Ibuprofen; Male; N-Formylmethionine Leucyl-Phenylalanine; Rabbits; Skin Diseases; Zymosan | 1989 |
Increased plasma chemoattractant in Sweet's syndrome.
Topics: Adult; Aspirin; Chemotaxis, Leukocyte; Dialysis; Hot Temperature; Humans; Isotretinoin; Leukocytosis; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pentose Phosphate Pathway; Phagocytosis; Plasma; Skin Diseases; Syndrome; Tretinoin; Zymosan | 1985 |
Safety and efficacy of ipragliflozin in elderly versus non-elderly Japanese patients with type 2 diabetes mellitus: a subgroup analysis of the STELLA-LONG TERM study.
Topics: Aged; Asian People; Blood Glucose; Body Mass Index; Body Weight; Diabetes Mellitus, Type 2; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incidence; Japan; Kidney Diseases; Lipoproteins, LDL; Male; Middle Aged; Product Surveillance, Postmarketing; Prospective Studies; Skin Diseases; Thiophenes; Treatment Outcome | 2018 |
Susceptibility to serious skin and subcutaneous tissue disorders and skin tissue distribution of sodium-dependent glucose co-transporter type 2 (SGLT2) inhibitors.
Topics: Animals; Glucose; Glucose Transporter Type 2; Glucosides; Humans; Hypoglycemic Agents; Japan; Rats; Skin Diseases; Sodium; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Subcutaneous Tissue; Thiophenes; Tissue Distribution | 2018 |
Cytoprotective effects of 6'-O-galloylpaeoniflorin against ultraviolet B radiation-induced cell damage in human keratinocytes.
Topics: Apoptosis Inducing Factor; Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Comet Assay; Cytoprotection; DNA Damage; Glucosides; Humans; In Situ Nick-End Labeling; Keratinocytes; Lipid Peroxidation; Monoterpenes; Reactive Oxygen Species; Skin Diseases; Ultraviolet Rays | 2014 |
Activity and stability studies of verbascoside, a novel antioxidant, in dermo-cosmetic and pharmaceutical topical formulations.
Topics: Administration, Topical; Antioxidants; Buddleja; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cosmetics; Drug Stability; Emulsions; Excipients; Glucosides; Humans; Hydrophobic and Hydrophilic Interactions; Inflammation; Intestinal Mucosa; Luminescence; Luminescent Measurements; Phenols; Skin; Skin Diseases; Solubility; Superoxides; Suppositories | 2011 |
[Clinical observation on Chinese herb Lei-Gong-Teng total glucosides in treatment of some dermatoses (author's transl)].
Topics: China; Female; Glucosides; Glycosides; Humans; Male; Middle Aged; Plant Extracts; Plants, Medicinal; Skin Diseases | 1979 |